Air cleared between Van Diepen and Van Commenée: summary proceedings have been dismissed

Former head coach Charles van Commenée of the Athletics Union will not institute summary proceedings against athlete Tony van Diepen. The 26-year-old athlete from Heerhugowaard accused his coach of insisting on the use of performance drug Thyrax in the past. Van Diepen withdraws that claim after serious discussions.

Tony van Diepen – Orange Pictures

Tony van Diepen announced last month that Van Commenée would have incited him to use Thyrax. This is a performance-enhancing drug that helps athletes lose weight faster. Van Commenée disagreed and filed a lawsuit.

Not encouraged

Before the case was filed, Van Diepen and Van Commenée referred their conflict to an independent sports law attorney. The lawyer says that firm discussions have been held, from which it became clear that Van Commenée did not encourage the use of Thyrax or other substances.

”I got the wrong feeling that Charles was encouraging the use of Thyrax”

athlete Tony van Diepen

Van Diepen: “At the beginning of 2019, we talked about looking for and setting boundaries in a broad sense. I wrongly got the feeling that Charles was encouraging the use of Thyrax.” De Heerhugowaarder regrets that Van Commenée has come under suspicion as a result.

Text continues below photo.

Charles van Commenée on the running track. – Pro Shots / Show Dip

Summons of the job

The 64-year-old Van Commenée ruled with relief after the outcome of the talks. “I stand for a clean sport and have always promoted that throughout my 45-year career. With Tony’s statement, I am pleased that the athletes’ results are now above suspicion again.”

According to the Amsterdammer, the summary proceedings against Van Diepen are now over.

Don’t want to miss anything from NH Sport?

  • Watch NH Sport on TV every Monday at 5.10 pm
  • Watch football talk show De Kick-off every Friday at 5.10 pm
  • Listen to NH Sport on NH Radio on Friday from 19-22 pm and Sunday from 17-19 pm
  • Like our Facebook page or follow us on Twitter